Frequency and nature of symptoms of dysfunction of the lower urinary tract in persons over 40 years old
Postcoital cystitis as a cause of sexual dysfunction in women
A modern view on the screening of urolithiasis
Hereditary factor of metaphylaxis of urolithiasis
Treatment of infertility associated with a high level of sperm DNA fragmentation
COVID-19 associated encrusting cystitis
Endoscopic correction of vesicoureteral reflux in children: differentiated choice of method, material and dosage
Male infertility in the Russian Federation: statistics for 2000-2018
Evaluation of the effectiveness of perineum muscle training in restoring erectile function
Epidemiology of urolithiasis in the Perm region: results of a 30-year study
The economic and economic rationale for the use of modern methods of treating urolithiasis
Incidence of ICD in the Russian Federation (2005-2016)
Screening for prostate cancer: modern presentation and organization
Primary multiple transitional cell epithelium
Androgenic screening in men over 50 years
The role of stem cells in the treatment of urinary incontinence
Percutaneous nephrolithotripsy in infected urine
Testicular Prosthesis in Children and Adolescents: Results from a Multicenter Study
Premature ejaculation is the current state of the problem.
Alternative methods of treatment of localized prostate cancer
Partial doubling of the urethra: paraurethral motion
Comparative review of disposable flexible ureteronephroscope
The prevalence of symptoms of impairment of the function of the lower urinary tract in men according to the results of a population study
Patient-centered system of organization of medical care in urology using...
Radioisotope lymphoscintigraphy with PCa
Metabolic risk factors and formation of urinary stones
Ureteral amputation in the performance of contact ureterolithotrypsy
Principles of «4P Medicine» in the organization of health care in the context of urological diseases
Changes in the electrolyte composition of urine under the influence of sodium hypochlorite. The possibility
of reducing the risk of recurrence of nephrolithiasis
The analysis of the accuracy of factors for the survival predictiry after radical cystectomy
Citokine status in pathients with recurrent urinary tract infection
The role of distance education in improving primary health care professionals.
Comparative analysis of the results of cancer radical retropubic and robot-assisted prostatectomy.
Experience of clinical and economical treatment cancer patients
Comparison of analysis details for open, laparoscopic
and robot-assisted nephrectomy in the..
First results of standardized programme for BPH diagnosis and treatment
Evaluation of serum Chromogranin A levels in different prostatic diseases
Retarded ejaculation is a rare diagnosis
Clinical and economic analysis of the surgical treatment of prostate cancer
Brachytherapy prostate cancer: postimplantnaya dosimetry and dependence ...
Simulation prostatic carcinogenesis
Experimental evaluation of the influence of isobornylphenols on the development of BPH and the redox potential of prostate cells DOI: 10.29188/2222-8543-2021-14-3-18-26
For citation:
Borovskaya T.G., Kamalova S.I., Kuchin A.V., Chukicheva I.Yu., Buravlev E.V., Krivova N.A., Zaeva O.B., Vychuzhanina A.V., Shchemerova Yu.A., Grigorieva V.A., Neplokhov E.A.,Vasilevsky R.P., Poluektova M.E. Experimental evaluation of the influence of isobornylphenols on the development of BPH and the redox potential of prostate cells. Experimental and Clinical Urology, 2021;14(3):18-26; https://doi.org/10.29188/2222-8543-2021-14-3-18-26
Borovskaya T.G. – Dr. Sc., Professor, Head of the Laboratory of pharmacology of the reproductive system, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center of the Russian Academy of Sciences; Tomsk, Russia; https://orcid.org/0000-0002-0651-4841
Kamalova S.I. – PhD. of Biological Sciences, Research Assistant of laboratory of pharmacology of the reproductive system, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center of the Russian Academy of Sciences; Tomsk, Russia; https://orcid.org/0000-0001-6403-7193
Kuchin A.V. – Dr. Sc (Chem.), Project Leader, Institute of Chemistry, Komi Scientific Centre, Ural Branch of the Russian Academy of Sciences; Syktyvkar, Russia; https://orcid.org/0000-0003-4322-7961
Chukicheva I.Yu. – DSc (Chem.), Project Leader, Institute of Chemistry, Komi Scientific Centre, Ural Branch of the Russian Academy of Sciences; Syktyvkar, Russia; https://orcid.org/0000-0002-7346-0812
Buravlev E.V. – PhD (Chem.), Senior Researcher, Institute of Chemistry, Komi Scientific Centre, Ural Branch of the Russian Academy of Sciences; Syktyvkar, Russia; https://orcid.org/0000-0002-7580-982X
Krivova N. A. – Dr. Sc., Professor, Head. laboratory of experimental physiology of a separate structural unit "Research Institute of Biophysics Biology, Tomsk State University"; Tomsk, Russia; https://orcid.org/0000-0002-3965-8665
Zaeva O. B. – PhD, researcher laboratory of Experimental Physiology of a separate structural unit «Research Institute of Biophysics Biology, Tomsk State University»; Tomsk, Russia
Vychuzhanina А.V. – Ph.D, Senior Research Officer of laboratory of pharmacology of the reproductive system, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center of the Russian Academy of Sciences; Tomsk, Russia; https://orcid.org/0000-0001-6151-0985
Shchemerovа Y.A. – Ph.D. of Biological Sciences, Research Officer of laboratory of pharmacology of the reproductive system, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center of the Russian Academy of Sciences; Tomsk, Russia; https://orcid.org/0000-0002-0895-9000
Grigorieva V.A. – Research Assistant of laboratory of pharmacology of the reproductive system, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center of the Russian Academy of Sciences; Tomsk, Russia; https://orcid.org/0000-0003-1863-088X
Neplokhov E.A. – MD, PhD, Regional State Autonomous Healthcare Institution «Regional Perinatal Center named after I.D. Evtushenko»; Tomsk, Russia
Vasilevsky R.P. – MD, Chief Freelance Specialist in Urology, Department of Healthcare in the South-West Administrative District, GBUZ City
Polyclinic No. 134 DZM; Moscow, Russia Poluektova M.E. – Ph.D. of Biological Sciences, Senior Research Officer of laboratory of pharmacology of the reproductive system, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center of the Russian Academy of Sciences; Tomsk, Russia; https://orcid.org/0000-0002-9052-3096
761
Introduction. Benign prostatic hyperplasia (BPH) is a common urological disorder in older men. It is characterized by the development of glandularstromal hyperplasia of the prostate with the formation of new glandular structures and subsequent symptoms from the lower urinary tract. It has now been established that the pathogenesis of this disease is multifactorial and one of the possible mechanisms for the development of BPH is oxidative stress.
Purpose. Study of the effect of phenols with a bulky isobornyl substituent (2,6-diisobornyl-4-methylphenol and 4-hydroxymethyl-2,6-diisobornylphenol) on the growth of experimental BPH and the antioxidant balance of prostate cells in comparison with Prostamol Uno.
Materials and мethods. Experiments were carried out on 50 male Wistar rats. BPH was caused by daily administration of sulpiride (60 days) to male rats of late reproductive age. After 2 months, the animals were weighed and sacrificed in a CO2 chamber. The mass, mass coefficient, volume of the lateral lobe of the pancreas were determined, morphological analysis was performed. Investigated prooxidant and antioxidant activity. The results were processed by the method of variation statistics using the Mann-Whitney nonparametric U test.
Results. The efficacy of the investigated drugs in BPH decreased in the following sequence: sulpiride + substance 4-hydroxymethyl-2,6-diisobornylphenol (HDB) → sulpiride + substance Dibornol (DB) → sulpiride + Prostamol Uno (PU). When comparing the results of evaluating the anti-prooxidant status with the therapeutic effect of the studied drugs, it was found that isobornylphenols, which are highly effective as prostatotropic drugs, did not show a more significant effect, compared to PU, on the redox potential of prostatic tissue cells.
Conclusions. Drugs DB, HDB, PU have a normalizing effect on the level of severity of redox reactions in the sulpiride model of BPH.
5-year impact factor of Russian science citation index from 15.01.2020 - 0,723
10-year H-index 21
Included in the Russian Science Citation Index (RSCI)
ISSN print 2222-8543 ISSN online 2712-8571
The journal is included in the List of Russian peer-reviewed scientific journals which should publish the main scientific results of dissertations for the degrees of Doctor and PhD of sciences
Поиск
International Classification
Сайт журнала "Экспериментальная и клиническая урология" содержит материалы
медицинского характера, предназначенные исключительно для работников
здравоохранения.
Подтвердите, пожалуйста, что Вы являетесь медицинским работником с соответствующим
дипломом или студентом медицинского образовательного учреждения.